KINDEX PHARMACEUTICALS
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders. It was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease. KinDex Pharmaceuticals is developing therapeutics that work through the Bitter Taste Receptors (TAS2Rs), a family of GPCR receptors that target inflammation and metabolic dysfunction.
KINDEX PHARMACEUTICALS
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2009-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.kindexpharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
206-922-2912
Email Addresses:
[email protected]
Total Funding:
5.83 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Network Solutions DNS Cogeco Peer 1
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Jeffrey Bland
Jeffrey Bland investment in Series A - KinDex Pharmaceuticals
Jeff Katke
Jeff Katke investment in Series A - KinDex Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series A - KinDex Pharmaceuticals
Official Site Inspections
http://www.kindexpharmaceuticals.com
- Host name: 66.81.203.135
- IP address: 66.81.203.135
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
